[MO41] Mini-Oral Session 41　Gastrointestinal Cancer 3（Colorectal Cancer 1）
【E】

[MO41-6] Mutant KRAS upregulates DNMT3B to inhibit STING for immune evasion and poor response to neoadjuvant chemoradiotherapy

^○Pei-Chen Yang¹, Chih-Yang Huang^2,3, K. S. Clifford Chao⁴, Wei-Ze Hung⁴, Shu-Fen Chiang⁵, Pei-Chun Lin⁴, Tsung-Wei Chen^6,7, Tao-Wei Ke^8,9, William Tzu-Liang Chen^8,10,11 (1.School of Post-Baccalaureate Chinese Medicine, China Medical University, Taiwan, 2.Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, Taiwan, 3.Translation Research Core, China Medical University Hospital, China Medical University, Taichung, Taiwan, 4.Proton Therapy and Science Center, China Medical University Hospital, China Medical University, Taichung, Taiwan, 5.Lab of Precision Medicine, Feng-Yuan Hospital, Ministry of Health and Welfare, Taichung, Taiwan, 6.Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, 7.Department of Pathology, Asia University Hospital, Asia University, Taichung, Taiwan, 8.Department of Colorectal Surgery, China Medical University Hospital, China Medical University, Taichung, Taiwan, 9.School of Chinese Medicine and Graduate Institute of Chinese Medicine, China Medical University, Taichung, Taiwan, 10.Department of Colorectal Surgery, China Medical University HsinChu Hospital, China Medical University, HsinChu, Taiwan, 11.School of Medicine, China Medical University, Taichung, Taiwan)